BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li D, Zhang R, Liu G, Kang Y, Wu J. Redox-Responsive Self-Assembled Nanoparticles for Cancer Therapy. Adv Healthc Mater 2020;9:e2000605. [PMID: 32893506 DOI: 10.1002/adhm.202000605] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhuang Y, Han S, Fang Y, Huang H, Wu J. Multidimensional transitional metal-actuated nanoplatforms for cancer chemodynamic modulation. Coordination Chemistry Reviews 2022;455:214360. [DOI: 10.1016/j.ccr.2021.214360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Tong T, Guan Y, Gao Y, Xing C, Zhang S, Jiang D, Yang X, Kang Y, Pang J. Smart nanocarriers as therapeutic platforms for bladder cancer. Nano Res 2022;15:2157-76. [DOI: 10.1007/s12274-021-3753-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ravula V, Lo YL, Wang LF, Patri SV. Gemini Lipopeptide Bearing an Ultrashort Peptide for Enhanced Transfection Efficiency and Cancer-Cell-Specific Cytotoxicity. ACS Omega 2021;6:22955-68. [PMID: 34514266 DOI: 10.1021/acsomega.1c03620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang L, Dai C, Fang Y, You X, Wu J. A drug/carrier dual redox-responsive system based on 6-mercaptopurine dimer-loaded cysteine polymer nanoparticles for enhanced lymphoma therapy. Nano Res . [DOI: 10.1007/s12274-021-4037-0] [Reference Citation Analysis]
5 Wang S, Hu X, Wei W, Ma G. Transformable vesicles for cancer immunotherapy. Adv Drug Deliv Rev 2021;179:113905. [PMID: 34331988 DOI: 10.1016/j.addr.2021.113905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
6 Zhang R, Nie T, Fang Y, Huang H, Wu J. Poly(disulfide)s: From Synthesis to Drug Delivery. Biomacromolecules 2021. [PMID: 34874705 DOI: 10.1021/acs.biomac.1c01210] [Reference Citation Analysis]
7 Zi L, Zhou W, Xu J, Li J, Li N, Xu J, You C, Wang C, Tian M. Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage. Int J Nanomedicine 2021;16:2933-47. [PMID: 33907400 DOI: 10.2147/IJN.S294916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ashrafizadeh M, Saebfar H, Gholami MH, Hushmandi K, Zabolian A, Bikarannejad P, Hashemi M, Daneshi S, Mirzaei S, Sharifi E, Kumar AP, Khan H, Heydari Sheikh Hossein H, Vosough M, Rabiee N, Thakur Kumar V, Makvandi P, Mishra YK, Tay FR, Wang Y, Zarrabi A, Orive G, Mostafavi E. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: Stimuli-responsive carriers, co-delivery and suppressing resistance. Expert Opin Drug Deliv 2022. [PMID: 35152815 DOI: 10.1080/17425247.2022.2041598] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
9 Yun K, Guo J, Zhu R, Wang T, Zhang X, Pan H, Pan W. Design of ROS-Responsive Hyaluronic Acid-Methotrexate Conjugates for Synergistic Chemo-Photothermal Therapy for Cancer. Mol Pharm 2022. [PMID: 35900105 DOI: 10.1021/acs.molpharmaceut.2c00472] [Reference Citation Analysis]
10 Han S, Wu J. Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy. Bioact Mater 2022;17:300-19. [PMID: 35386452 DOI: 10.1016/j.bioactmat.2022.01.020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ren G, Duan D, Wang G, Wang R, Li Y, Zuo H, Zhang Q, Zhang G, Zhao Y, Wang R, Zhang S. Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity. Colloids Surf B Biointerfaces 2022;217:112614. [PMID: 35700564 DOI: 10.1016/j.colsurfb.2022.112614] [Reference Citation Analysis]
12 Cong X, Chen J, Xu R. Recent Progress in Bio-Responsive Drug Delivery Systems for Tumor Therapy. Front Bioeng Biotechnol 2022;10:916952. [DOI: 10.3389/fbioe.2022.916952] [Reference Citation Analysis]
13 Singh R, Sharma A, Saji J, Umapathi A, Kumar S, Daima HK. Smart nanomaterials for cancer diagnosis and treatment. Nano Convergence 2022;9. [DOI: 10.1186/s40580-022-00313-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zheng Y, Lei J, Li Q, Jin X, Li Q, Li Y. Interfacial cationization to quicken redox-responsive drug release. Chem Commun 2021;57:2943-6. [DOI: 10.1039/d1cc00156f] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Liu S, Li L, Zhang X, Meng Q. Nanotherapies from an oncologist doctor's view. Smart Materials in Medicine 2022. [DOI: 10.1016/j.smaim.2022.07.005] [Reference Citation Analysis]
16 Yang Y, Wu H, Liu B, Liu Z. Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment. Adv Drug Deliv Rev 2021;179:114004. [PMID: 34662672 DOI: 10.1016/j.addr.2021.114004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
17 Gong X, Wang Z, Zhang L, Dong W, Wang R, Liu Y, Song S, Hu Q, Du F, Shuang S, Dong C. A novel carbon-nanodots-based theranostic nano-drug delivery system for mitochondria-targeted imaging and glutathione-activated delivering camptothecin. Colloids Surf B Biointerfaces 2022;218:112712. [PMID: 35921692 DOI: 10.1016/j.colsurfb.2022.112712] [Reference Citation Analysis]
18 Chen Q, Xu S, Liu S, Wang Y, Liu G. Emerging nanomedicines of paclitaxel for cancer treatment. J Control Release 2022;342:280-94. [PMID: 35016919 DOI: 10.1016/j.jconrel.2022.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
19 Guo Y, Wang M, Zou Y, Jin L, Zhao Z, Liu Q, Wang S, Li J. Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer. J Nanobiotechnology 2022;20:371. [PMID: 35953863 DOI: 10.1186/s12951-022-01586-4] [Reference Citation Analysis]
20 Yan P, Luo Y, Li X, Li Y, Wang Y, Wu J, Zhou S. A Redox-Responsive Nanovaccine Combined with A2A Receptor Antagonist for Cancer Immunotherapy. Adv Healthc Mater 2021;10:e2101222. [PMID: 34494380 DOI: 10.1002/adhm.202101222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]